Claribine Trial recruiting RRMS participants

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Claribine Trial recruiting RRMS participants

Postby JFH » Tue Aug 15, 2006 9:23 am

The CLARITY Study is a double-blind clinical trial of an oral form (tablet) of the investigational medicine Cladribine. Certain forms of Cladribine are approved for use in other illnesses, but research is still needed on treating multiple sclerosis with Cladribine tablets.

The study is testing a Cladribine tablet against a placebo tablet (an inactive look-alike tablet). Some questions researchers hope to answer are:

Does this study drug decrease the number of relapses?
Does this study drug decrease the number of MRI lesions?
Is the study drug safe, as well as effective?

The purpose of the CLARITY study is to evaluate the safety and effectiveness of Cladribine tablets. Researchers are testing two different doses of Cladribine tablets against placebo.

All participants in the study will be given either Cladribine tablets or placebo tablets. The chance of getting Cladribine tablets is 2 out of 3.

I am what I am
User avatar
Family Elder
Posts: 288
Joined: Sun Jul 11, 2004 3:00 pm
Location: England


Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service